Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Accounts receivable, net

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Apr 30, 202417-9.04%
Apr 30, 202318-10.95%
Apr 30, 202221+9.05%
Apr 30, 202119+118.94%
Apr 30, 20209+16.71%
Apr 30, 20197+96.43%
Apr 30, 20184-51.51%
Apr 30, 20178+170.79%
Apr 30, 20163-25.02%
Apr 30, 20154+186.26%
Apr 30, 20141-19.86%
Apr 30, 20132-29.37%
Apr 30, 20122

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat